Search the web
Sign In
New User? Sign Up
nathanfaustmantrials · JoinLeeNow Nathan/Faustman Trials Group
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Want your group to be featured on the Yahoo! Groups website? Add a group photo to Flickr.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
Mistake in Faustman's Lab Web Page? (CFA is described as non-toxic,   Message List  
Reply | Forward Message #584 of 634 |
Re: Mistake in Faustman's Lab Web Page? (CFA is described as non-toxic, but is toxic)

I can't speak to the toxicity of the dosage used in the trial mice. When I spoke
with Dr. Faustman at some length (see DiabetesDaily interview) she mentioned
that CFA was toxic to humans. This was in the context of discussing whether a
single dose of BCG would 'cure' diabetes. She said that in mice CFA seems to be
a permanent cure with a single dose. But to develop the same for humans would
require new drug development.

I suspect (not from talking with her) that if BCG works, we'll end up taking a
dose of BCG on a regular basis in place of insulin. But we won't need to test
our blood sugar. I'd inject daily if I knew that highs and lows were gone. That
would be a huge win for me.

Bernard
http://blog.bernardfarrell.com/


--- In nathanfaustmantrials@yahoogroups.com, "Ivan Roseland" <iroseland@...>
wrote:
>
> --- In nathanfaustmantrials@yahoogroups.com, Joshua Levy <joshua2levy@> wrote:
> >
> >
> > Faustman's new lab web page contains the following quote:
> >
> > In research published in 2001 in the Journal of Clinical Investigation and
in 2003 in Science,
> > Dr. Faustman and colleagues used a brief, non-toxic treatment to induce
> > TNF-a in end-stage diabetic mice and permanently eliminate their
> > disease.
> > (from http://www.faustmanlab.org/research/research.html)
> > But this is an obvious mistake: Faustman's treatment described in the paper
uses CFA, which is highly toxic to people and animals.
> >
> > Take a look at the 2001 paper. The abstract clearly says:
> >
> > Hyperglycemic NOD mice were treated with CFA to induce TNF-� expression
> > and were exposed to functional complexes of MHC class I molecules and
> > antigenic peptides either by repeated injection of MHC class I matched
> > splenocytes or by transplantation of islets from nonautoimmune donors.
> > (from http://www.jci.org/articles/view/12335)
> >
> > And CFA (Complete Freud's Adjuvant) is well known to be toxic. So toxic
that it can not be used in people at all, and is discouraged even in animals, as
show here:
> >
> > (CFA) is quite toxic and cannot be used in humans.
> > (from
http://books.google.com/books?id=TFoIXMe-UEEC&pg=PA403&lpg=PA403&dq=complete+Fre\
und%27s+adjuvant+CFA+safety&source=web&ots=dYXKq2PcQ-&sig=zrlavn3Lmahle2DArr02aE\
1_Ib8&hl=en&sa=X&oi=book_result&resnum=10&ct=result
)
> > and also
> >
> > The undesirable side effects attributed to CFA use include increased pain
and suffering and morbidity in inoculated test animals
> > (from http://www.vcu.edu/oehs/chemical/biosafe/CFAinfo.pdf)
> > and here:
> >
> > The
> > best example of this is complete Freund's adjuvant (CFA). While it
> > remains the gold standard in terms of adjuvant potency, its extreme
> > reactogenicity and toxicity precludes its use in human vaccines, and
> > there have been discussions of banning CFA even in veterinary vaccines.
> > (from
http://biopharminternational.findpharma.com/biopharm/Downstream+Processing/New-A\
ge-Vaccine-Adjuvants-Friend-or-Foe/ArticleStandard/Article/detail/444996
)
> >
> > So it sounds like the description of Faustman's treatment as "non-toxic', as
is done in her lab's web site, is a mistake. The experiment used CFA, which is
toxic. Or is there something I'm missing? Does someone know why Faustman's
web page refers to this treatment as non-toxic? Is there something about her
formulation or dosing that makes it safe? (This question has nothing to do with
the safety of Faustman's current clincial trial, because that trial uses BCG.
From a safety point of view, BCG and CFA are quite different.)
> >
> > Joshua Levy
> >
>
>
> I think by non-toxic they meant a doseage that was not known to cause the
toxic side effects... Also, she has made a point of telling folks that part of
the research is to find a human tolerable replacement for CFA.
>
> Ivan





Tue Mar 24, 2009 1:08 am

bernfarr
Offline Offline
Send Email Send Email

Forward
Message #584 of 634 |
Expand Messages Author Sort by Date

Faustman's new lab web page contains the following quote: In research published in 2001 in the Journal of Clinical Investigation and in 2003 in Science, Dr....
Joshua Levy
joshua2levy
Online Now Send Email
Jan 6, 2009
11:51 am

... I think by non-toxic they meant a doseage that was not known to cause the toxic side effects... Also, she has made a point of telling folks that part of...
Ivan Roseland
iroseland
Offline Send Email
Mar 24, 2009
12:58 am

I can't speak to the toxicity of the dosage used in the trial mice. When I spoke with Dr. Faustman at some length (see DiabetesDaily interview) she mentioned...
Bernard Farrell
bernfarr
Offline Send Email
Mar 25, 2009
12:29 pm

The substance that is being used in the human trials is BCG. Dr. Faustman later used BCG in the mice, instead of CFA, with the same successful outcome of...
Sue root
susan_root
Offline Send Email
Mar 25, 2009
12:32 pm
Advanced

Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help